Je was op zoek naar: pneumococcal (Engels - Deens)

pneumococcal
streptococcus pneumoniae

pneumococcal vaccine
pneumokok-vaccine

pneumococcal conjugate vaccine
konjugat pneumokok-vaccine

look at pneumococcal disease.
se blot på pneumokokfremkaldt sygdom.

ipd invasive pneumococcal disease
ipd invasiv pneumokoksygdom

pneumococcal invasive disease(s)
invasiv(e) pneumokoksygdom(me)

prevenar is a pneumococcal vaccine.
prevenar er en pneumokokvaccine.

pneumococcal polysaccharide serotype 11 2.2 µg
pneumokok polysaccharid serotype 11 2,2 µg

pneumococcal polysaccharide serotype 11,2 1 microgram
pneumokokpolysaccharid serotype 11,2 1 mikrogram

pneumococcal polysaccharide conjugate vaccine (adsorbed)
konjugeret pneumokokpolysaccharidvaccine (adsorberet)

187 multivalent pneumococcal polysaccharide vaccine at week 4.
170 kontrolleret klinisk undersøgelse med voksne patienter med psoriasis artrit, modtog 184 af patienterne også en multivalent pneumokok polysakkarid vaccine i uge 4.

pneumococcal saccharide conjugated vaccine, adsorbed intramuscular use.
konjugeret saccharid pneumokokvaccine, adsorberet intramuskulær brug

pneumococcal penicillin resistance is now prevalent in many countries.
penicillinresistens hos pneumokokker er nu almindelig i mange lande.

pneumococcal invasive disease(s) (streptococcus pneumoniae)
invasiv pneumokoksygdom(me) (streptococcus pneumoniae)

pneumococcal polysaccharide conjugate vaccine (13 valent, adsorbed)
konjugeret pneumokok polysaccharidvaccine (13-valent, adsorberet)

prevenar suspension for injection pneumococcal saccharide conjugated vaccine, adsorbed
prevenar, injektionsvæske, suspension konjugeret saccharid pneumokokvaccine, adsorberet

adults not previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
voksne, der ikke tidligere er vaccineret med 23-valent pneumokok polysaccharidvaccine

pharmacotherapeutic group: vaccines, pneumococcal vaccines; atc code: j07al02
farmakoterapeutisk klassifikation: vacciner, pneumokokvacciner; atc-kode: j07al02

42%), reduced rates to pneumococcal polysaccharide vaccine (43% vs.
42%), der var reduceret respons over for pneumokok polysaccharid vaccine (43% vs.

prevenar suspension for injection pneumococcal saccharide conjugated vaccine, adsorbed intramuscular use.
prevenar, injektionsvæske, suspension konjugeret saccharid pneumokokvaccine, adsorberet intramuskulær brug